| |
| |
|
| Insider
Information: |
Sethuraman Natarajan |
| Relationship: |
Chief Scientific Officer |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
209,032 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
209,032 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Entrada Therapeutics, Inc. |
TRDA |
Chief Scientific Officer |
2024-03-05 |
209,032 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-03-05 |
4 |
D |
$12.28 |
$18,480 |
D/D |
(1,505) |
209,032 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-03-04 |
4 |
D |
$12.42 |
$9,845 |
D/D |
(761) |
210,537 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
44,100 |
211,298 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-09-05 |
4 |
D |
$14.46 |
$6,494 |
D/D |
(449) |
167,198 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,200 |
167,647 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-07-11 |
4 |
AS |
$18.04 |
$267,915 |
D/D |
(14,852) |
153,447 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-07-10 |
4 |
AS |
$18.00 |
$54,474 |
D/D |
(3,026) |
168,299 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-04-17 |
4 |
AS |
$18.00 |
$71,316 |
D/D |
(3,961) |
171,325 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-02 |
4 |
D |
$11.60 |
$12,269 |
D/D |
(1,058) |
189,486 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
14,200 |
175,286 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,400 |
190,544 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,794 |
162,144 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,588 |
156,350 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Scientific OfficerOffice |
• – – |
2021-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
144,762 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
